Skip to main content
. 2022 Sep 19;48(5):197. doi: 10.3892/or.2022.8412

Table I.

Clinicopathological features of patients with PCa.

Clinical features No. of cases (%)
Age, years
  <73 25 (49.02)
  ≥73 26 (50.98)
Pathological grade
  BPH 5 (9.80)
  GS=6 10 (19.61)
  GS=7 10 (19.61)
  GS=8 11 (21.57)
  GS=9 12 (23.53)
  GS=10 3 (5.88)
PSA level, pg/ml
  <54.3 25 (49.02)
  ≥54.3 26 (50.98)

PCa, prostate cancer; BPH, benign prostate hyperplasia; GS, Gleason score; PSA, prostate specific antigen.